Prevalence of hyperuricemia and its related risk factors among preschool children from China

Nan Li1, Shuang Zhang1, Weiqin Li1

  • 1Tianjin Women and Children's Health Center, Tianjin, China.

Scientific Reports
|August 27, 2017
PubMed

Insights

The prevalence of hyperuricemia in Chinese preschool children is high, affecting 10.1% of those aged 3-6 years. Male sex and obesity are key risk factors for this condition.

Area of Science:

  • Pediatrics
  • Public Health
  • Metabolic Disorders

Background:

  • Hyperuricemia, characterized by elevated serum uric acid levels, is increasingly recognized as a health concern in pediatric populations.
  • Understanding its prevalence and risk factors in young children is crucial for early intervention and prevention strategies.

Purpose of the Study:

  • To determine the prevalence of hyperuricemia among preschool children in urban China.
  • To identify major risk factors associated with hyperuricemia in this age group.

Main Methods:

  • A cross-sectional survey was conducted in Tianjin, China, involving 4073 preschool children aged 3-6 years.
  • Cluster sampling was used to ensure a representative sample.
  • Logistic regression analysis was employed to identify risk factors and calculate odds ratios.

Main Results:

  • The overall prevalence of hyperuricemia (serum uric acid ≥ 310 μmol/L) was 10.1%.
  • Mean serum uric acid levels were higher in boys (247.3 ± 53.7 μmol/L) than in girls (238.3 ± 52.4 μmol/L).
  • In univariable analysis, male sex, obesity, elevated diastolic blood pressure, and high serum triglyceride levels were associated with hyperuricemia, though the latter two lost significance in multivariable models.

Conclusions:

  • Hyperuricemia prevalence is relatively high in Chinese preschool children.
  • Obesity and male sex are significant risk factors for hyperuricemia in this population.
  • Components of metabolic syndrome may be associated with an increased risk of hyperuricemia in young children.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
469
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
607
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353